157 related articles for article (PubMed ID: 26282165)
21. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.
Lee KH; Ahn EJ; Oh SJ; Kim O; Joo YE; Bae JA; Yoon S; Ryu HH; Jung S; Kim KK; Lee JH; Moon KS
Oncotarget; 2015 Feb; 6(5):3240-53. PubMed ID: 25605251
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of RPN2 suppresses radiosensitivity of glioma cells by activating STAT3 signal transduction.
Li C; Ran H; Song S; Liu W; Zou W; Jiang B; Zhao H; Shao B
Mol Med; 2020 May; 26(1):43. PubMed ID: 32404045
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin.
Colomiere M; Findlay J; Ackland L; Ahmed N
Int J Biochem Cell Biol; 2009 May; 41(5):1034-45. PubMed ID: 18930836
[TBL] [Abstract][Full Text] [Related]
24. A STAT3-based gene signature stratifies glioma patients for targeted therapy.
Tan MSY; Sandanaraj E; Chong YK; Lim SW; Koh LWH; Ng WH; Tan NS; Tan P; Ang BT; Tang C
Nat Commun; 2019 Aug; 10(1):3601. PubMed ID: 31399589
[TBL] [Abstract][Full Text] [Related]
25. Zerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2/STAT3 pathway and increases paclitaxel sensitivity.
Jorvig JE; Chakraborty A
Anticancer Drugs; 2015 Feb; 26(2):160-6. PubMed ID: 25243457
[TBL] [Abstract][Full Text] [Related]
26. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.
Fedele M; Cerchia L; Pegoraro S; Sgarra R; Manfioletti G
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167470
[TBL] [Abstract][Full Text] [Related]
27. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
[TBL] [Abstract][Full Text] [Related]
28. Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner.
Kiprianova I; Remy J; Milosch N; Mohrenz IV; Seifert V; Aigner A; Kögel D
Neoplasia; 2015 Jul; 17(7):564-73. PubMed ID: 26297434
[TBL] [Abstract][Full Text] [Related]
29. Increased in vivo angiogenic effect of glioma stromal mesenchymal stem-like cells on glioma cancer stem cells from patients with glioblastoma.
Kong BH; Shin HD; Kim SH; Mok HS; Shim JK; Lee JH; Shin HJ; Huh YM; Kim EH; Park EK; Chang JH; Kim DS; Hong YK; Kim SH; Lee SJ; Kang SG
Int J Oncol; 2013 May; 42(5):1754-62. PubMed ID: 23483121
[TBL] [Abstract][Full Text] [Related]
30. Importance of PKCδ signaling in fractionated-radiation-induced expansion of glioma-initiating cells and resistance to cancer treatment.
Kim MJ; Kim RK; Yoon CH; An S; Hwang SG; Suh Y; Park MJ; Chung HY; Kim IG; Lee SJ
J Cell Sci; 2011 Sep; 124(Pt 18):3084-94. PubMed ID: 21878493
[TBL] [Abstract][Full Text] [Related]
31. Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.
Turner KM; Sun Y; Ji P; Granberg KJ; Bernard B; Hu L; Cogdell DE; Zhou X; Yli-Harja O; Nykter M; Shmulevich I; Yung WK; Fuller GN; Zhang W
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3421-6. PubMed ID: 25737557
[TBL] [Abstract][Full Text] [Related]
32. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
[TBL] [Abstract][Full Text] [Related]
33. The modulation of microRNAs by type I IFN through the activation of signal transducers and activators of transcription 3 in human glioma.
Ohno M; Natsume A; Kondo Y; Iwamizu H; Motomura K; Toda H; Ito M; Kato T; Wakabayashi T
Mol Cancer Res; 2009 Dec; 7(12):2022-30. PubMed ID: 19934272
[TBL] [Abstract][Full Text] [Related]
34. Dobesilate inhibits the activation of signal transducer and activator of transcription 3, and the expression of cyclin D1 and bcl-XL in glioma cells.
Cuevas P; Díaz-González D; Sánchez I; Lozano RM; Giménez-Gallego G; Dujovny M
Neurol Res; 2006 Mar; 28(2):127-30. PubMed ID: 16551428
[TBL] [Abstract][Full Text] [Related]
35. Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition.
Segerman A; Niklasson M; Haglund C; Bergström T; Jarvius M; Xie Y; Westermark A; Sönmez D; Hermansson A; Kastemar M; Naimaie-Ali Z; Nyberg F; Berglund M; Sundström M; Hesselager G; Uhrbom L; Gustafsson M; Larsson R; Fryknäs M; Segerman B; Westermark B
Cell Rep; 2016 Dec; 17(11):2994-3009. PubMed ID: 27974212
[TBL] [Abstract][Full Text] [Related]
36. The transcriptional regulatory network of proneural glioma determines the genetic alterations selected during tumor progression.
Sonabend AM; Bansal M; Guarnieri P; Lei L; Amendolara B; Soderquist C; Leung R; Yun J; Kennedy B; Sisti J; Bruce S; Bruce R; Shakya R; Ludwig T; Rosenfeld S; Sims PA; Bruce JN; Califano A; Canoll P
Cancer Res; 2014 Mar; 74(5):1440-1451. PubMed ID: 24390738
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis.
Niola F; Zhao X; Singh D; Sullivan R; Castano A; Verrico A; Zoppoli P; Friedmann-Morvinski D; Sulman E; Barrett L; Zhuang Y; Verma I; Benezra R; Aldape K; Iavarone A; Lasorella A
J Clin Invest; 2013 Jan; 123(1):405-17. PubMed ID: 23241957
[TBL] [Abstract][Full Text] [Related]
38. Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells.
Ahmed SU; Carruthers R; Gilmour L; Yildirim S; Watts C; Chalmers AJ
Cancer Res; 2015 Oct; 75(20):4416-28. PubMed ID: 26282173
[TBL] [Abstract][Full Text] [Related]
39. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
Kim SH; Ezhilarasan R; Phillips E; Gallego-Perez D; Sparks A; Taylor D; Ladner K; Furuta T; Sabit H; Chhipa R; Cho JH; Mohyeldin A; Beck S; Kurozumi K; Kuroiwa T; Iwata R; Asai A; Kim J; Sulman EP; Cheng SY; Lee LJ; Nakada M; Guttridge D; DasGupta B; Goidts V; Bhat KP; Nakano I
Cancer Cell; 2016 Feb; 29(2):201-13. PubMed ID: 26859459
[TBL] [Abstract][Full Text] [Related]
40. A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells.
Barciszewska AM; Gurda D; Głodowicz P; Nowak S; Naskręt-Barciszewska MZ
PLoS One; 2015; 10(8):e0136669. PubMed ID: 26309255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
